{"content":"<li class=\"n-box-item date-title\" data-end=\"1492142399\" data-start=\"1492056000\" data-txt=\"Monday, December 23, 2019\">Thursday, April 13, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3257176\" data-ts=\"1492124794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRP\" target=\"_blank\">STRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257176-straight-pathplus-3_6-on-word-of-possible-verizon-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Straight Path +3.6% on word of possible Verizon bid</a></h4><ul>     <li>Straight Path Communications (NYSEMKT:<a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a>) is <font color='green'>up 3.6%</font> after hours on a report that Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) is considering topping AT&amp;T's (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) $1.25B bid for the small spectrum holder.</li>     <li>A <a href=\"https://seekingalpha.com/filing/3504127\" target=\"_blank\">Straight Path filing</a> mentions a third party evaluating an offer who today sent a letter to the company about topping AT&amp;T; <a href=\"http://www.reuters.com/article/us-straight-path-m-a-at-t-idUSKBN17F2R9\" target=\"_blank\">Reuters reports that's Verizon</a>.</li>   <li>Straight Path is holding prized millimeter-wave spectrum that will be key to 5G networking; both AT&amp;T and Verizon have been conducting trials of the next-gen standard.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3257176\" data-linked=\"Straight Path +3.6% on word of possible Verizon bid\" data-tweet=\"$STRP $STRP $VZ - Straight Path +3.6% on word of possible Verizon bid https://seekingalpha.com/news/3257176-straight-pathplus-3_6-on-word-of-possible-verizon-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3257176-straight-pathplus-3_6-on-word-of-possible-verizon-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257172\" data-ts=\"1492122408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CS\" target=\"_blank\">CS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257172-credit-suisse-ceo-board-to-cut-variable-pay-40\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse CEO, board to cut their variable pay 40%</a></h4><ul>   <li>The board and CEO at Credit Suisse (<a href=\"http://seekingalpha.com/symbol/CS\" target=\"_blank\">CS</a> <font color='red'>-1.6%</font>) have agreed to a 40% cut in variable compensation, after some shareholders expressed reservations about the pay.</li>    <li>The board's also decided to keep total board compensation at the level it was in 2016 and 2015, scrapping a plan presented at the annual meeting to increase it incrementally. The new proposal suggests that compensation made up long-term incentives for 2017 and short-term incentives for 2016 be cut by 40% each.</li>    <li>After hours, shares are <font color='green'>up 0.5%</font>.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257172\" data-linked=\"Credit Suisse CEO, board to cut their variable pay 40%\" data-tweet=\"$CS - Credit Suisse CEO, board to cut their variable pay 40% https://seekingalpha.com/news/3257172-credit-suisse-ceo-board-to-cut-variable-pay-40?source=tweet\" data-url=\"https://seekingalpha.com/news/3257172-credit-suisse-ceo-board-to-cut-variable-pay-40\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257168\" data-ts=\"1492121162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257168-t-mobile-dish-network-dominate-spectrum-spending-top-two-stand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile, Dish Network dominate spectrum spending as top two stand by</a></h4><ul>   <li>As it had promised, T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='green'>+0.2%</font>) <a href=\"https://seekingalpha.com/news/3257118-t-mobile-key-winner-fcc-spectrum-auction\" target=\"_blank\">made a splash</a> at the FCC's yearlong spectrum auction, making its biggest-ever investment ($7.99B) to acquire more than 1,500 licenses nationwide (45% of the spectrum auctioned).</li>    <li>That's a move that will <a href=\"http://www.lightreading.com/mobile/spectrum/t-mobile-dish-and-comcast-big-winners-in-$198b-600mhz-auction-/d/d-id/732097?_mc=RSS_LR_EDT\" target=\"_blank\">help its network catch up</a> to those of wireless leaders AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-0.7%</font>) and Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='red'>-0.6%</font>), who largely sat out this sale (but in large part because their eyes are <a href=\"https://seekingalpha.com/news/3256703-moodys-ts-straight-path-purchase-strategic-positive\" target=\"_blank\">turned forward to 5G implementation</a>, rather than more 4G spectrum).</li>    <li>But it will take time. For one thing, there's a \"repack\" ahead where TV broadcasting airwaves are repurposed for mobile use, and that may take a few years before they're put into action. T-Mobile chief John Legere promises it will put 600 MHz spectrum to use \"later this year,\" with 1M square miles cleared for use by the end of 2017.</li>    <li>Investors may disapprove of Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color='red'>-2.5%</font>) spending $6.2B on more than 480 licenses, adding to its heavy spending in the last spectrum auction. That spending won't quiet speculation about M&amp;A activity; the company has a huge cache of spectrum and no currently known plan for how it will implement it, short of pairing with an existing provider.</li>    <li>Behind T-Mobile and Dish, but also gathering airwaves, Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-0.4%</font>) spent $1.7B on 73 licenses (and <a href=\"https://seekingalpha.com/pr/16799491-comcast-corporation-statement-fcc-broadcast-incentive-auction-results\" target=\"_blank\">got $481.6M in the reverse auction</a>, after giving up NBC-owned spectrum in New York, Philadelphia and Chicago). AT&amp;T spent $910M for 23 licenses -- a drop in the bucket at the huge carrier. U.S. Cellular (<a href=\"http://seekingalpha.com/symbol/USM\" target=\"_blank\">USM</a> <font color='red'>-2.1%</font>) spent $328M but got 188 licenses, with a rural focus.</li>    <li>With a good hoard of spectrum and a relatively bigger cash problem, Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='red'>-0.7%</font>) sat out this round. But is T-Mobile still in need of a merger partner in Sprint, now that it's taking on a sizable amount of prime low-band airwaves?</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color='green'>+0.7%</font>; <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='red'>-0.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257168\" data-linked=\"T-Mobile, Dish Network dominate spectrum spending as top two stand by\" data-tweet=\"$TMUS $TMUS $CMCSA - T-Mobile, Dish Network dominate spectrum spending as top two stand by https://seekingalpha.com/news/3257168-t-mobile-dish-network-dominate-spectrum-spending-top-two-stand?source=tweet\" data-url=\"https://seekingalpha.com/news/3257168-t-mobile-dish-network-dominate-spectrum-spending-top-two-stand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>190&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257164\" data-ts=\"1492119616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257164-after-hours-gainers-losers-of-5-25-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers as of 5:25 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SABR' title='Sabre Corporation'>SABR</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/PDLI' title='PDL BioPharma, Inc.'>PDLI</a> <font color='green'>+3%</font>. ITEK <font color='green'>+2%</font>. <a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='green'>+2%</font>. <a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='green'>+2%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='red'>-4%</font>. <a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='red'>-2%</font>. <a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color='red'>-2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257164\" data-linked=\"After Hours Gainers / Losers as of 5:25 PM\" data-tweet=\"$SABR $PDLI $RCKT - After Hours Gainers / Losers as of 5:25 PM https://seekingalpha.com/news/3257164-after-hours-gainers-losers-of-5-25-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257164-after-hours-gainers-losers-of-5-25-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257155\" data-ts=\"1492116387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257155-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='green'>+13.4%</font>. <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='green'>+5.6%</font>. <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a> <font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/SIVR' title='ETFS Physical Silver Trust ETF'>SIVR</a> <font color='green'>+3%</font>. <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a> <font color='green'>+3%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='red'>-4.3%</font>. <a href='https://seekingalpha.com/symbol/KOL' title='VanEck Vectors Coal ETF'>KOL</a> <font color='red'>-3.6%</font>. <a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='red'>-2.8%</font>. <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a> <font color='red'>-2.7%</font>. <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='red'>-2.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257155\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$VXX $OIL $GDX - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3257155-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3257155-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257134\" data-ts=\"1492113178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257134-gold-closes-out-big-week-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold closes out big week with more gains</a></h4><ul><li>Geopolitical tension ratcheted higher all week, culminating (for now) in the U.S. <a href=\"https://seekingalpha.com/news/3257107-u-s-strikes-isis-afghanistan\" target=\"_blank\">today hitting</a> an ISIS target in Afghanistan with a massive bunker buster bomb.</li><li>Naturally benefitting was the yellow metal, which gained $35 per ounce, or&nbsp;<font color='green'>nearly 3%</font>&nbsp;this week, including a<font color='green'> 0.9% advance</font>&nbsp;today.</li><li>At $1,290 per ounce, it's at its highest since early November.</li><li><font color='green'>Up 11.75%</font>&nbsp;in 2017, <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a> is outperforming the S&amp;P 500 by 750 basis points.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='ETFS Physical Swiss Gold Trust ETF'>SGOL</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='PowerShares DB Gold ETF'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/GYEN' title='AdvisorShares Gartman Gold/Yen ETF'>GYEN</a>, <a href='https://seekingalpha.com/symbol/GEUR' title='AdvisorShares Gartman Gold/Euro ETF'>GEUR</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/QGLDX' title='The Gold Bullion Strategy Fund Inv'>QGLDX</a>, <a href='https://seekingalpha.com/symbol/GHE' title='REX Gold Hedged FTSE Emerging Markets ETF'>GHE</a>, <a href='https://seekingalpha.com/symbol/GHS' title='REX Gold Hedged S&P 500 ETF'>GHS</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3257134\" data-linked=\"Gold closes out big week with more gains\" data-tweet=\"$GLD $IAU $PHYS - Gold closes out big week with more gains https://seekingalpha.com/news/3257134-gold-closes-out-big-week-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3257134-gold-closes-out-big-week-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257129\" data-ts=\"1492110051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257129-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> OIBR-C <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a> <font color='red'>-37%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257129\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$STRM $AEHR $INPX - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3257129-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257129-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257123\" data-ts=\"1492107281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FXCOF\" target=\"_blank\">FXCOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257123-report-toshiba-suspends-chip-business-sale-amid-western-digital-questions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Toshiba suspends chip-business sale amid Western Digital questions</a></h4><ul>    <li>Toshiba (<a href=\"http://seekingalpha.com/symbol/TOSYY\" target=\"_blank\">TOSYY</a> <font color='red'>-6%</font>) has <a href=\"https://www.bloomberg.com/news/articles/2017-04-13/toshiba-said-to-put-temporary-hold-on-memory-chip-sale-process\" target=\"_blank\">temporarily suspended</a> meetings and decisions about the sale of its NAND memory chip business to address concerns raised by Western Digital (<a href=\"http://seekingalpha.com/symbol/WDC\" target=\"_blank\">WDC</a> <font color='red'>-0.6%</font>) about whether the auction process can proceed, Bloomberg reports.</li>    <li>Western Digital has suggested that splitting off the unit as Toshiba Memory before a sale <a href=\"https://seekingalpha.com/news/3256712-toshiba-chip-bidders-four-western-digital-raises-flag\" target=\"_blank\">violates a joint venture contract</a> it has with Toshiba, and that bidding is running above fair and supportable value for the business. It wants exclusive talks over buying the unit, and RBC's Amit Daryanani believes WDC has an <a href=\"https://seekingalpha.com/news/3256876-broadcom-likely-win-toshiba-bidding-rbc\" target=\"_blank\">effective veto right</a>.</li>    <li>Toshiba disagrees with WDC on that. After reports that Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color='green'>+1.5%</font>) had submitted a &yen;2T bid, Foxconn (<a href='https://seekingalpha.com/symbol/FXCOF' title='FOXCONN TECH CO LTD ORD'>OTC:FXCOF</a>) has reportedly come up with an offer to pay &yen;3T (about $27B).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3257095-bloomberg-broadcom-financing-lined-18_3b-toshiba-chip-bid\" target=\"_blank\">Bloomberg: Broadcom has financing lined up for $18.3B Toshiba chip bid</a> (Apr. 13 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257123\" data-linked=\"Report: Toshiba suspends chip-business sale amid Western Digital questions\" data-tweet=\"$FXCOF $FXCOF $TOSYY - Report: Toshiba suspends chip-business sale amid Western Digital questions https://seekingalpha.com/news/3257123-report-toshiba-suspends-chip-business-sale-amid-western-digital-questions?source=tweet\" data-url=\"https://seekingalpha.com/news/3257123-report-toshiba-suspends-chip-business-sale-amid-western-digital-questions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257120\" data-ts=\"1492106450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257120-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FMSA' title='Fairmount Santrol, Inc.'>FMSA</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257120\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$YUMA $SBGL $GFI - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3257120-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257120-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257118\" data-ts=\"1492106238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257118-t-mobile-up-key-winner-in-fcc-spectrum-auction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile up as key winner in FCC spectrum auction</a></h4><ul>   <li>T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) has jumped to its highest point this month, <font color='green'>+0.5%</font>, on word that it's a key winner in the FCC's $19.8B broadcast incentive spectrum auction.</li>    <li>Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>) was also among the biggest buyers of spectrum, though its stock is headed the opposite direction, <font color='red'>tumbling 1.8%</font>.</li>    <li>Other key takers: Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) and U.S. Cellular (<a href=\"http://seekingalpha.com/symbol/USM\" target=\"_blank\">USM</a> <font color='red'>-1.4%</font>).</li><li>Despite qualifying for the sale, Verizon (<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a> <font color='red'>-0.4%</font>) didn't bid.</li><li><a href=\"https://apps.fcc.gov/edocs_public/attachmatch/DA-17-314A1.pdf\" target=\"_blank\">FCC Public Notice</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3257118\" data-linked=\"T-Mobile up as key winner in FCC spectrum auction\" data-tweet=\"$TMUS $TMUS $DISH - T-Mobile up as key winner in FCC spectrum auction https://seekingalpha.com/news/3257118-t-mobile-up-key-winner-in-fcc-spectrum-auction?source=tweet\" data-url=\"https://seekingalpha.com/news/3257118-t-mobile-up-key-winner-in-fcc-spectrum-auction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257117\" data-ts=\"1492105930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLNK\" target=\"_blank\">NLNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257117-incyteplus-2-morgan-stanley-ups-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Incyte +2%; Morgan Stanley ups price target</a></h4><ul><li>\"We increasingly believe epacadostat possesses superior efficacy and safety relative to other IDO competitors, resulting in a best-in-class profile,\" <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/04/13/morgan-stanley-ups-incyte-target-to-150/?mod=BOL_hp_blog_stw\" target=\"_blank\">says Andrew Berens</a>, following data presented <a href=\"https://seekingalpha.com/news/3256230-incyte-boosted-bulls-barclays\" target=\"_blank\">last week at the</a> AACR conference.</li><li>\"Specifically, we think NewLink&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a>) indoximod may have less efficacy and a less favorable tolerability profile, while Bristol&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) &lsquo;986205 appears to be pushing a potentially narrow therapeutic window to gain a once daily dosing advantage.\"</li><li>Berens and team reiterate an Outperform rating on Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>), and boost the price target to $150 from $130.</li><li>Shares are&nbsp;<font color='green'>up 2.1%</font>&nbsp;today to $141.16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257117\" data-linked=\"Incyte +2%; Morgan Stanley ups price target\" data-tweet=\"$NLNK $NLNK $BMY - Incyte +2%; Morgan Stanley ups price target https://seekingalpha.com/news/3257117-incyteplus-2-morgan-stanley-ups-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3257117-incyteplus-2-morgan-stanley-ups-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257108\" data-ts=\"1492103143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257108-financials-top-5-gainers-losers-of-1-05-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:05 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> WAC <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257108\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:05 PM\" data-tweet=\"$HGSH $DHCP - Financials - Top 5 Gainers / Losers as of 1:05 PM https://seekingalpha.com/news/3257108-financials-top-5-gainers-losers-of-1-05-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257108-financials-top-5-gainers-losers-of-1-05-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257102\" data-ts=\"1492102157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CADE\" target=\"_blank\">CADE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257102-rare-bank-ipo-off-to-strong-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rare bank IPO off to strong start</a></h4><ul><li>Cadence Bancorp (NYSE:<a href='https://seekingalpha.com/symbol/CADE' title='Cadence Bancorporation'>CADE</a>) priced its 7.5M-share IPO at the midpoint of the hoped-for $19-$21 price range. In early post-IPO action, shares are trading hands at $21.79 each,&nbsp;<font color='green'>up 8.95%</font>.</li><li>Goldman Sachs and JPMorgan were the lead underwriters.</li><li>In addition to serving as a proxy about what investors think about smaller banks given the economic and regulatory environment, Cadence is based in Houston and thus has business subject to the volatile energy markets.</li><li>Cadence was formed in 2009 to buy up failed or struggling lenders. It wanted to go public a couple of years back, but postponed that idea thanks to the energy sector blowup.</li><li>Source: <a href=\"https://www.wsj.com/articles/as-ipos-heat-up-this-texas-bank-wants-in-1491998402\" target=\"_blank\">Christina Rexrode and Corrie Driebusch in the <em>WSJ</em></a></li></ul><div class=\"tiny-share-widget\" data-id=\"3257102\" data-linked=\"Rare bank IPO off to strong start\" data-tweet=\"$CADE - Rare bank IPO off to strong start https://seekingalpha.com/news/3257102-rare-bank-ipo-off-to-strong-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3257102-rare-bank-ipo-off-to-strong-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257098\" data-ts=\"1492100081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PII\" target=\"_blank\">PII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257098-polaris-industries-down-1_8-on-vehicle-recall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Polaris Industries down 1.8% on vehicle recall</a></h4><ul><li>The company <a href=\"https://seekingalpha.com/pr/16799277-polaris-voluntarily-recalls-certain-road-vehicles\" target=\"_blank\">is voluntarily recalling </a>certain 2015 Ranger 900s due to faulty fasteners on the heat shield, as well as certain 2017 Sportsman ATVs due to a potentially faulty electronic power steering unit. In total, nearly 55K vehicles are subject to the recall.</li><li>No injuries have been reported from any of the recalled units.</li><li><a href='https://seekingalpha.com/symbol/PII' title='Polaris Industries Inc.'>PII</a><font color='red'> -1.8%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3257098\" data-linked=\"Polaris Industries down 1.8% on vehicle recall\" data-tweet=\"$PII - Polaris Industries down 1.8% on vehicle recall https://seekingalpha.com/news/3257098-polaris-industries-down-1_8-on-vehicle-recall?source=tweet\" data-url=\"https://seekingalpha.com/news/3257098-polaris-industries-down-1_8-on-vehicle-recall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257090\" data-ts=\"1492099532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257090-invivo-to-amend-inspire-protocol-up-to-40-new-patients-to-participate-shares-slump-6-on\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InVivo to amend INSPIRE protocol, up to 40 new patients to participate; shares slump 6% on efficacy implications</a></h4><ul><li>Thinly traded micro cap InVivo Therapeutics (<a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-5.6%</font>) eases on modestly higher volume in response to its <a href=\"https://seekingalpha.com/filing/3503058\" target=\"_blank\">announcement </a>that it intends to amend the protocol for the Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02138110?term=invivo+therapeutics&amp;rank=1\" target=\"_blank\">INSPIRE </a>study evaluating its Neuro-Spinal Scaffold in patients with acute spinal cord injury. The company says the change will allow the recruitment of an additional 20 - 40 patients who were initially rejected because they did not meet all the inclusion criteria. It plans to submit the amended protocol to the FDA this quarter.</li><li>Frequently, a study sponsor increases enrollment when interim data aren't as robust as desired. According to ClinicalTrials.gov, the estimated final data collection date for the primary efficacy endpoint is June, which InVivo says will not change due to the additional treatment arm.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257090\" data-linked=\"InVivo to amend INSPIRE protocol, up to 40 new patients to participate; shares slump 6% on efficacy implications\" data-tweet=\"$NVIV - InVivo to amend INSPIRE protocol, up to 40 new patients to participate; shares slump 6% on efficacy implications https://seekingalpha.com/news/3257090-invivo-to-amend-inspire-protocol-up-to-40-new-patients-to-participate-shares-slump-6-on?source=tweet\" data-url=\"https://seekingalpha.com/news/3257090-invivo-to-amend-inspire-protocol-up-to-40-new-patients-to-participate-shares-slump-6-on\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257095\" data-ts=\"1492099485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257095-bloomberg-broadcom-financing-lined-up-for-18_3b-toshiba-chip-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Broadcom has financing lined up for $18.3B Toshiba chip bid</a></h4><ul>   <li>Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color='green'>+1.8%</font>) has <a href=\"https://www.bloomberg.com/news/articles/2017-04-13/broadcom-said-to-win-japan-banks-backing-for-toshiba-chip-bid\" target=\"_blank\">lined up financing</a> for its presumed &yen;2T (about $18.3B) bid for the chip business at Toshiba (<a href=\"http://seekingalpha.com/symbol/TOSYY\" target=\"_blank\">TOSYY</a> <font color='red'>-4.2%</font>), Bloomberg says.</li>    <li>Financing isn't only coming from bid partner Silver Lake ($3B in convertible debt) but also three Japanese banks, sources said: some $15B in loans from Mizuho, Sumitomo Mitsui, and Mitsubishi UFJ.</li>    <li>Mizuho and Sumitomo Mitsui are also primary banks for Toshiba.</li>   <li>Meanwhile, Western Digital (<a href=\"http://seekingalpha.com/symbol/WDC\" target=\"_blank\">WDC</a> <font color='red'>-0.3%</font>) is throwing up objections to the auction process, particularly to any deal with Broadcom. RBC's Amit Daryanan hears that WDC has the <a href=\"https://seekingalpha.com/news/3256876-broadcom-likely-win-toshiba-bidding-rbc\" target=\"_blank\">ability to block other bidders</a>.</li>    <li>The second round of bids for the business is due May 19.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256712-toshiba-chip-bidders-four-western-digital-raises-flag\" target=\"_blank\">Toshiba chip bidders down to four; Western Digital raises flag</a> (Apr. 12 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256516-toshiba-files-quarterly-report-without-auditor-endorsement\" target=\"_blank\">Toshiba files quarterly report without auditor endorsement</a> (Apr. 11 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257095\" data-linked=\"Bloomberg: Broadcom has financing lined up for $18.3B Toshiba chip bid\" data-tweet=\"$AVGO $AVGO $TOSYY - Bloomberg: Broadcom has financing lined up for $18.3B Toshiba chip bid https://seekingalpha.com/news/3257095-bloomberg-broadcom-financing-lined-up-for-18_3b-toshiba-chip-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3257095-bloomberg-broadcom-financing-lined-up-for-18_3b-toshiba-chip-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257093\" data-ts=\"1492099283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257093-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul><li><b>Losers:</b> SPU <font color='red'>-44%</font>. <a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257093\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FTFT $DTEA $SORL - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3257093-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3257093-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257091\" data-ts=\"1492099140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPE\" target=\"_blank\">CPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257091-callon-petroleum-upgraded-to-buy-euro-pacific\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Callon Petroleum upgraded to Buy at Euro Pacific</a></h4><ul>     <li>Callon Petroleum (<a href='https://seekingalpha.com/symbol/CPE' title='Callon Petroleum Co.'>CPE</a> <font color='red'>-1.9%</font>) is lower despite receiving an <a href=\"https://www.streetinsider.com/Analyst+Comments/Stifel+Starts+Callon+Petroleum+%28CPE%29+at+Buy/12773628.html\" target=\"_blank\">upgrade to Buy</a> from Neutral with a $17 price target at Euro Pacific Capital, citing the recent pullback in commodity prices, its strong balance sheet, and high quality  prospects in the Midland and Delaware Basins.</li><li>The firm believes CPE shares are in strong position to appreciate as the  company continues to develop its asset base or with a favorable  commodity price rally.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257091\" data-linked=\"Callon Petroleum upgraded to Buy at Euro Pacific\" data-tweet=\"$CPE - Callon Petroleum upgraded to Buy at Euro Pacific https://seekingalpha.com/news/3257091-callon-petroleum-upgraded-to-buy-euro-pacific?source=tweet\" data-url=\"https://seekingalpha.com/news/3257091-callon-petroleum-upgraded-to-buy-euro-pacific\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257087\" data-ts=\"1492098021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GKOS\" target=\"_blank\">GKOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257087-glaukos-likely-to-overturn-istent-rate-cut-noridian-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glaukos likely to overturn iStent rate cut by Noridian - Wells Fargo</a></h4><ul><li>Bullish sell-sider Wells Fargo believes Glaukos (<a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a> <font color='red'>-6.7%</font>) should be able to reverse Noridian's plan to significantly cut physician reimbursement for implanting an iStent to lower intraocular pressure in glaucoma patients. Noridian proposes reducing payments to $200 - 300 from the current $800 -900 effective May 10.</li><li>Wells' Lawrence Biegelsen says the lower reimburse rate only applies to procedures performed in doctors' offices, not those done at facilities. He adds that the lower rate is based on a misguided comparison with another IOP-lowering procedure called <a href=\"http://www.webmd.com/eye-health/laser-trabeculoplasty-for-glaucoma\" target=\"_blank\">laser trabeculoplasty</a>. He maintains his Outperform rating on the stock saying the ultimate reimbursement rate should settle out at $500 - 600.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3257087\" data-linked=\"Glaukos likely to overturn iStent rate cut by Noridian - Wells Fargo\" data-tweet=\"$GKOS - Glaukos likely to overturn iStent rate cut by Noridian - Wells Fargo https://seekingalpha.com/news/3257087-glaukos-likely-to-overturn-istent-rate-cut-noridian-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/3257087-glaukos-likely-to-overturn-istent-rate-cut-noridian-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257081\" data-ts=\"1492096638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GKOS\" target=\"_blank\">GKOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257081-medicare-contractor-noridian-proposes-rate-cut-for-glaukos-istent-shares-slump-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medicare contractor Noridian proposes rate cut for Glaukos&#39; iStent; shares slump 6%</a></h4><ul><li>Glaukos (<a href='https://seekingalpha.com/symbol/GKOS' title='Glaukos'>GKOS</a> <font color='red'>-6.3%</font>) is down on increased volume in response to the news that Medicare Administrative Contractor Noridian has proposed lowering the level of physician reimbursement for implanting glaucoma device iStent.</li><li>Source: The Fly</li></ul><div class=\"tiny-share-widget\" data-id=\"3257081\" data-linked=\"Medicare contractor Noridian proposes rate cut for Glaukos&#39; iStent; shares slump 6%\" data-tweet=\"$GKOS - Medicare contractor Noridian proposes rate cut for Glaukos&#39; iStent; shares slump 6% https://seekingalpha.com/news/3257081-medicare-contractor-noridian-proposes-rate-cut-for-glaukos-istent-shares-slump-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3257081-medicare-contractor-noridian-proposes-rate-cut-for-glaukos-istent-shares-slump-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257079\" data-ts=\"1492096135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257079-sorrento-prices-stock-offering-2-shares-down-33\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento prices stock offering at $2; shares down 33%</a></h4><ul><li>Sorrento Therapeutics (<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='red'>-33.1%</font>) <a href=\"https://seekingalpha.com/pr/16799108-sorrento-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of ~23.6M shares of common stock at $2 per share. Underwriters over-allotment is an additional ~3.5M shares.</li><li>Yesterday's close was $2.95.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257079\" data-linked=\"Sorrento prices stock offering at $2; shares down 33%\" data-tweet=\"$SRNE - Sorrento prices stock offering at $2; shares down 33% https://seekingalpha.com/news/3257079-sorrento-prices-stock-offering-2-shares-down-33?source=tweet\" data-url=\"https://seekingalpha.com/news/3257079-sorrento-prices-stock-offering-2-shares-down-33\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257078\" data-ts=\"1492095772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNN\" target=\"_blank\">RNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257078-rexahn-pharma-to-reverse-split-stock-1-10-shares-off-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rexahn Pharma to reverse split stock 1:10; shares off 17%</a></h4><ul><li>With the aim of goosing institutional demand, Rexahn Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a> <font color='red'>-17.2%</font>) plans to <a href=\"https://seekingalpha.com/pr/16798985-rexahn-announces-1minus-10-reverse-stock-split\" target=\"_blank\">execute </a>a 1:10 reverse split of its common shares on May 5. Post-split trading will commence that day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257078\" data-linked=\"Rexahn Pharma to reverse split stock 1:10; shares off 17%\" data-tweet=\"$RNN $REXN - Rexahn Pharma to reverse split stock 1:10; shares off 17% https://seekingalpha.com/news/3257078-rexahn-pharma-to-reverse-split-stock-1-10-shares-off-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3257078-rexahn-pharma-to-reverse-split-stock-1-10-shares-off-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257056\" data-ts=\"1492095735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257056-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NVET' title='Nexvet Biopharma'>NVET</a> <font color='green'>+64%</font>. <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products'>EYES</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/DMTX' title='Dimension Therapeutics'>DMTX</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/JNP' title='Juniper Pharmaceuticals, Inc.'>JNP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-9%</font>. APRI <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257056\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$NVET $OCRX $FCSC - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3257056-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3257056-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257075\" data-ts=\"1492095358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTZ\" target=\"_blank\">MTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257075-mastec-upgraded-to-buy-d-davidson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MasTec upgraded to Buy at D.A. Davidson</a></h4><ul>     <li>MasTec (<a href='https://seekingalpha.com/symbol/MTZ' title='MasTec, Inc.'>MTZ</a> <font color='green'>+4.9%</font>) is <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9296726/expect-mastec-shares-to-continue-outperforming-over-the-\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $50 price target, raised from $44, at D.A. Davidson, which sees potential catalysts included listed bookings momentum, communications customer initiative developments and/or potential M&amp;A.</li>     <li>The firm also notes that MTZ's underperforming transmission unit seems to be on the upswing, and expects an abundance of project proposals to drive further bookings momentum.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257075\" data-linked=\"MasTec upgraded to Buy at D.A. Davidson\" data-tweet=\"$MTZ - MasTec upgraded to Buy at D.A. Davidson https://seekingalpha.com/news/3257075-mastec-upgraded-to-buy-d-davidson?source=tweet\" data-url=\"https://seekingalpha.com/news/3257075-mastec-upgraded-to-buy-d-davidson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257074\" data-ts=\"1492095094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBLS\" target=\"_blank\">GBLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257074-globus-maritime-files-to-sell-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globus Maritime files to sell shares</a></h4><ul>     <li>Globus Maritime (<a href='https://seekingalpha.com/symbol/GBLS' title='Global Industries Corp.'>OTC:GBLS</a>)&nbsp;files to sell 36.4M shares. The tally includes 32.4M shares exercisable by warrants. Chairman Georgios Feidakis is among the sellers.</li>     <li><a href=\"https://seekingalpha.com/filing/3502967\" target=\"_blank\">SEC Form F-3</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3257074\" data-linked=\"Globus Maritime files to sell shares\" data-tweet=\"$GBLS - Globus Maritime files to sell shares https://seekingalpha.com/news/3257074-globus-maritime-files-to-sell-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3257074-globus-maritime-files-to-sell-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257073\" data-ts=\"1492094822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKYW\" target=\"_blank\">SKYW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257073-skywest-soars-off-of-raymond-james-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SkyWest soars off of Raymond James optimism</a></h4><ul> <li>SkyWest (NASDAQ:<a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a>) soars after Raymond James arrives with a Strong Buy rating to lift sentiment on the airline stock. A new regional contract with United and improvements to existing contracts underpin the upgrade from Outperform.</li> <li>The firm sets a high-flying price target of $42 on SkyWest. Shares are <font color='green'>up 8.31%</font> to $32.92 today.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3257073\" data-linked=\"SkyWest soars off of Raymond James optimism\" data-tweet=\"$SKYW - SkyWest soars off of Raymond James optimism https://seekingalpha.com/news/3257073-skywest-soars-off-of-raymond-james-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3257073-skywest-soars-off-of-raymond-james-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257072\" data-ts=\"1492094703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257072-wells-fargo-exception-big-banks-advance-on-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo the exception as big banks advance on earnings</a></h4><ul><li>Wells' (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='red'>-1.3%</font>) Q1 efficiency ratio of 62.7% (worsening from 61.2% in Q4 and 58.7% a year ago) is \"not acceptable,\" says CEO Tim Sloan, speaking on the earnings call (<a href=\"http://thefly.com/landingPageNews.php?id=2533885&amp;headline=WFC;JPM;PNC-Wells-Fargo-CEO-says-Qs-efficiency-ratio-level-not-acceptable\" target=\"_blank\">reporting by TheFly</a>). He's expecting efficiency initiatives to cut expenses by about $2B annually by the end of next year.</li><li>With much work left to do post-scandal, a new marketing campaign is set to get going next week.</li><li>Also on the call, CFO John Shrewsberry says he expects auto lending to continue to decline, along with Q2 mortgage production.</li><li>There's good news in wealth management though, with a 9% jump in client assets to $1.8T. Advisory assets were up 14% to $490B - these are especially lucrative as they generate recurring fees as opposed to commissions.</li><li>On their post-earnings call, Jamie Dimon and Marianne Lake (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color='green'>+1.1%</font>) say they're <a href=\"http://www.wsj.com/livecoverage/jpmorgan-wells-fargo-and-citi-report-first-quarter-earnings?mod=cjx\" target=\"_blank\">not concerned about</a> the slowdown in lending growth, noting the comparison is affected by large acquisitions in last year's Q1.</li><li>Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='green'>+1.5%</font>), PNC Financial (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color='green'>+2.7%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3257022-lending-slowdown-wells-fargo-shares-1_7-percent-premarket\" target=\"_blank\">Lending slowdown at Wells Fargo; shares down 1.7% premarket</a> (April 13)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256984-investment-banking-drives-jpm-beat-consumer-results-weaken\" target=\"_blank\">Investment banking drives JPM beat; consumer results weaken</a> (April 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3257072\" data-linked=\"Wells Fargo the exception as big banks advance on earnings\" data-tweet=\"$WFC $WFC $JPM - Wells Fargo the exception as big banks advance on earnings https://seekingalpha.com/news/3257072-wells-fargo-exception-big-banks-advance-on-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3257072-wells-fargo-exception-big-banks-advance-on-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257069\" data-ts=\"1492094484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257069-shopify-jumps-on-loose-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopify jumps on loose takeover chatter</a></h4><ul> <li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a>) is <font color='green'>up 2.80%</font> as takeover rumors swirl about the Canadian e-commerce stock.</li> <li>The chatter at this point isn't backed by any concrete reporting.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3257069\" data-linked=\"Shopify jumps on loose takeover chatter\" data-tweet=\"$SHOP - Shopify jumps on loose takeover chatter https://seekingalpha.com/news/3257069-shopify-jumps-on-loose-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3257069-shopify-jumps-on-loose-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257067\" data-ts=\"1492094198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEA\" target=\"_blank\">DTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257067-post-earnings-slide-for-davidstea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings slide for DAVIDsTEA</a></h4><ul>     <li>DAVIDsTEA (<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a> <font color='red'>-13.9%</font>) announced sales increased 14% to C$86.3M in FQ4.</li>     <li>Comparable sales increased by 0.4% Y/Y.</li>     <li>Gross profit as a percent of sales fell back to 51.9% from 55.7% a year ago. The company says the drop was tied to additional promotional activity, a shift in product sales mix and the adverse impact from the stronger U.S.dollar.</li>     <li>CEO&nbsp;Joel Silver, \"Despite the weakness in our Q4 financial performance, in fiscal 2016 we made progress in key areas including continuing to grow our e-commerce business, maximizing the potential of our loyalty program, and executing several in-store tests which have resulted in a number of learnings that we will utilize to drive sales, improve the customer experience and achieve operational efficiencies going forward.&nbsp;Looking ahead, fiscal 2017 will be a reset year for DAVIDsTEA.\"</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16798255-davidstea-inc-announces-fourth-quarter-fiscal-2016-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3257067\" data-linked=\"Post-earnings slide for DAVIDsTEA\" data-tweet=\"$DTEA - Post-earnings slide for DAVIDsTEA https://seekingalpha.com/news/3257067-post-earnings-slide-for-davidstea?source=tweet\" data-url=\"https://seekingalpha.com/news/3257067-post-earnings-slide-for-davidstea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257066\" data-ts=\"1492094158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIVI\" target=\"_blank\">IIVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257066-analysts-applied-optoelectronics-set-to-build-on-q1-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts: Applied Optoelectronics set to build on Q1 numbers</a></h4><ul>   <li>Data-center demand can keep driving upside for Applied Optoelectronics (<a href=\"http://seekingalpha.com/symbol/AAOI\" target=\"_blank\">AAOI</a> <font color='green'>+13.9%</font>), analysts say after the company dropped some <a href=\"https://seekingalpha.com/news/3256950-applied-optoelectronics-sees-q1-results-far-guidance\" target=\"_blank\">preliminary Q1 numbers</a> that exceeded expectations by far.</li>    <li>Along with revenue estimates at least 5.7% higher than forecast, and net income nearly 15% higher, gross margins are coming in more at 42.5% to 42.9%, above expectations for 38-40%.</li>    <li>That's due to big (and still growing demand) from major data-center players including Facebook, Amazon.com and Microsoft, as well as some supply constraints in 100G transceivers.</li>    <li>\"The vast majority of the 100G opportunity still lies ahead,\" says Cowen's Paul Silverstein, who has one of the highest price targets after boosting it to $75 from $66 (more than 60% upside). The company can keep boosting gross margins despite price erosion due to vertical integration among 100G components, he says.</li>    <li>Jefferies notes peers most likely to benefit from Applied's successful results: Chiefly Finisar (<a href=\"http://seekingalpha.com/symbol/FNSR\" target=\"_blank\">FNSR</a> <font color='green'>+3.1%</font>), along with Oclaro (<a href=\"http://seekingalpha.com/symbol/OCLR\" target=\"_blank\">OCLR</a> <font color='green'>+0.9%</font>), Lumentum (<a href=\"http://seekingalpha.com/symbol/LITE\" target=\"_blank\">LITE</a> <font color='green'>+1.6%</font>) and Mellanox (<a href=\"http://seekingalpha.com/symbol/MLNX\" target=\"_blank\">MLNX</a> <font color='green'>+0.5%</font>). Q2 guidance should be strong, analyst James Kisner notes, with China resuming purchases and hyperscale demand ramping up.</li>    <li>Related tickers on the move: <a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a> <font color='green'>+2.7%</font>, <a href='https://seekingalpha.com/symbol/FN' title='Fabrinet'>FN</a> <font color='green'>+2.7%</font>, <a href='https://seekingalpha.com/symbol/VIAV' title='Viavi Solutions Inc.'>VIAV</a> <font color='green'>+0.7%</font>, <a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a> <font color='green'>+2%</font>, <a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a> <font color='green'>+4.2%</font>, <a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='green'>+0.4%</font>, <a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='green'>+2.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3257066\" data-linked=\"Analysts: Applied Optoelectronics set to build on Q1 numbers\" data-tweet=\"$IIVI $IIVI $FN - Analysts: Applied Optoelectronics set to build on Q1 numbers https://seekingalpha.com/news/3257066-analysts-applied-optoelectronics-set-to-build-on-q1-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3257066-analysts-applied-optoelectronics-set-to-build-on-q1-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>110&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257065\" data-ts=\"1492093862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257065-natural-gas-inventory-builds-slightly-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds slightly more than expected</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a>&nbsp;<strong>+10 Bcf</strong> vs. +9 Bcf consensus, +2 Bcf last week.</li><li>Futures&nbsp;<font color='green'>+1.32%</font>&nbsp;to $3.229.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3257065\" data-linked=\"Natural gas inventory builds slightly more than expected\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds slightly more than expected https://seekingalpha.com/news/3257065-natural-gas-inventory-builds-slightly-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3257065-natural-gas-inventory-builds-slightly-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257062\" data-ts=\"1492093045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXCM\" target=\"_blank\">DXCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257062-dexcom-under-mild-pressure-on-apple-project-for-non-invasive-glucose-monitoring-for-diabetics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DexCom under mild pressure on Apple project for non-invasive glucose monitoring for diabetics; shares ease 2%</a></h4><ul><li>Continuous glucose monitoring device maker DexCom (<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color='red'>-1.9%</font>) is under early pressure in apparent response to the news that tech giant Apple is secretly <a href=\"https://seekingalpha.com/news/3256942-cnbc-apple-secret-effort-diabetes-treatment\" target=\"_blank\">developing </a>non-invasive glucose sensors. Google parent Alphabet is reportedly on a similar track with its with smart contact lens technology.</li><li>DexCom's <a href=\"https://www.dexcom.com/continuous-glucose-monitoring\" target=\"_blank\">gear </a>requires a small wire to be inserted underneath the skin in order to measure glucose levels.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257062\" data-linked=\"DexCom under mild pressure on Apple project for non-invasive glucose monitoring for diabetics; shares ease 2%\" data-tweet=\"$DXCM - DexCom under mild pressure on Apple project for non-invasive glucose monitoring for diabetics; shares ease 2% https://seekingalpha.com/news/3257062-dexcom-under-mild-pressure-on-apple-project-for-non-invasive-glucose-monitoring-for-diabetics?source=tweet\" data-url=\"https://seekingalpha.com/news/3257062-dexcom-under-mild-pressure-on-apple-project-for-non-invasive-glucose-monitoring-for-diabetics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257046\" data-ts=\"1492090580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZTS\" target=\"_blank\">ZTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257046-nexvet-bio-up-big-on-85m-bid-from-zoetis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nexvet Bio up big on $85M bid from Zoetis</a></h4><ul><li>Zoetis (<a href='https://seekingalpha.com/symbol/ZTS' title='Zoetis'>ZTS</a> <font color='red'>-0.2%</font>) inks an <a href=\"https://seekingalpha.com/pr/16799068-zoetis-acquire-nexvet-biopharma-innovator-monoclonal-antibody-therapies-companion-animals\" target=\"_blank\">agreement </a>to acquire companion animal therapeutics developer Nexvet Biopharma (<a href='https://seekingalpha.com/symbol/NVET' title='Nexvet Biopharma'>NVET</a> <font color='green'>+66.7%</font>) for $6.72 per share ($85M), a 66% premium over yesterday's close of $4.05.</li><li>Nexvet's pipeline includes ranevetmab to treat osteoarthritis pain in dogs and cats and a PD-1 program for canine cancer.</li><li>The deal should close in H2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257046\" data-linked=\"Nexvet Bio up big on $85M bid from Zoetis\" data-tweet=\"$ZTS $ZTS $NVET - Nexvet Bio up big on $85M bid from Zoetis https://seekingalpha.com/news/3257046-nexvet-bio-up-big-on-85m-bid-from-zoetis?source=tweet\" data-url=\"https://seekingalpha.com/news/3257046-nexvet-bio-up-big-on-85m-bid-from-zoetis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257047\" data-ts=\"1492090482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNC\" target=\"_blank\">PNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257047-pnc-financialplus-0_75-after-earnings-beat-optimistic-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PNC Financial +0.75% after earnings beat, optimistic outlook</a></h4><ul><li>Q1 net income of $1.074B or $1.96 per share vs. $943M and $1.68 one year ago.</li><li>More than 90% of Q1 income returned to shareholders with $500M in buybacks and $300M in dividends. CET 1 ratio of 10.5% down 10 basis points from three months earlier. Tangible book value per share of $67.47 vs. $65.15 a year ago.</li><li>Net interest margin of 2.77% up two basis points Y/Y.</li><li><a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=107246&amp;p=irol-EventDetails&amp;EventId=5249992\" target=\"_blank\">Earnings call slides</a>: Management sees 2017 revenue growth at upper end of mid-single-digit range vs. estimates for 4%.</li><li><a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a>&nbsp;<font color='green'>+0.75%</font>&nbsp;in early action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3256967-pnc-financial-beats-0_13-beats-revenue\" target=\"_blank\">PNC Financial beats by $0.13, beats on revenue</a> (April 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3257047\" data-linked=\"PNC Financial +0.75% after earnings beat, optimistic outlook\" data-tweet=\"$PNC - PNC Financial +0.75% after earnings beat, optimistic outlook https://seekingalpha.com/news/3257047-pnc-financialplus-0_75-after-earnings-beat-optimistic-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3257047-pnc-financialplus-0_75-after-earnings-beat-optimistic-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257044\" data-ts=\"1492090094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSN\" target=\"_blank\">CLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257044-celsions-thermodox-significantly-improves-efficiency-of-chemo-in-bladder-cancer-model-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celsion&#39;s ThermoDox significantly improves efficiency of chemo in bladder cancer model; shares ahead 20% premarket</a></h4><ul><li>Penny stock Celsion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>) is up&nbsp;<font color='green'>20%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16798865-celsion-corporation-reports-preclinical-results-thermodox-treatment-bladder-cancer-published\" target=\"_blank\">announcement </a>of positive preclinical results for ThermoDox. The data were just published in the <em>International Journal of Hyperthermia</em>.</li><li>In a porcine bladder cancer model, the combination of ThermoDox and mild hyperthermia achieved almost a 10x improvement in the concentration of doxorubicin within the bladder wall compared to free intravenous doxorubicin combined with mild hyperthermia.</li><li>ThermoDox is encapsulated doxorubicin. After infusion, it is heated to a specific temperature which releases the cancer drug directly into a tumor.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2427106-celsion-up-32-percent-premarket-on-positive-interim-results-for-thermodox\" target=\"_blank\">Celsion up 32% premarket on positive interim results for ThermoDox</a> (April 15, 2015)</li></ul><div class=\"tiny-share-widget\" data-id=\"3257044\" data-linked=\"Celsion&#39;s ThermoDox significantly improves efficiency of chemo in bladder cancer model; shares ahead 20% premarket\" data-tweet=\"$CLSN - Celsion&#39;s ThermoDox significantly improves efficiency of chemo in bladder cancer model; shares ahead 20% premarket https://seekingalpha.com/news/3257044-celsions-thermodox-significantly-improves-efficiency-of-chemo-in-bladder-cancer-model-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3257044-celsions-thermodox-significantly-improves-efficiency-of-chemo-in-bladder-cancer-model-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257040\" data-ts=\"1492089504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLMD\" target=\"_blank\">RLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257040-relmadas-lead-product-candidate-relminus-1017-fast-trackd-for-mdd-shares-ahead-20-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Relmada&#39;s lead product candidate REL-1017 Fast Track&#39;d for MDD; shares ahead 20% premarket</a></h4><ul><li>Thinly traded nano cap Relmada Therapeutics (<a href='https://seekingalpha.com/symbol/RLMD' title='Relmada Therapeutics, Inc.'>OTCQB:RLMD</a>) is up&nbsp;<font color='green'>20%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16798772-relmada-announces-fda-fast-track-designation-d-methadone-adjunctive-treatment-major\" target=\"_blank\">announcement </a>that the FDA has designated lead product candidate, Phase 2a-stage REL-1017 (dextromethadone, d-Methadone), for Fast Track review for the adjunctive treatment of major depressive disorder &#40;MDD&#41;.</li><li>Fast Track status provides for more frequent interactions with the FDA review team and a rolling review of the New Drug Application &#40;NDA&#41;.</li><li><a href=\"http://www.relmada.com/product-candidates/rel-1017-d-methadone\" target=\"_blank\">Dextromethadone </a>is a single isomer of methadone but has no opioid- or ketamine-like toxicities. It is being developed to treat neuropathic pain in addition to depression.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257040\" data-linked=\"Relmada&#39;s lead product candidate REL-1017 Fast Track&#39;d for MDD; shares ahead 20% premarket\" data-tweet=\"$RLMD - Relmada&#39;s lead product candidate REL-1017 Fast Track&#39;d for MDD; shares ahead 20% premarket https://seekingalpha.com/news/3257040-relmadas-lead-product-candidate-relminus-1017-fast-trackd-for-mdd-shares-ahead-20-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3257040-relmadas-lead-product-candidate-relminus-1017-fast-trackd-for-mdd-shares-ahead-20-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257038\" data-ts=\"1492089248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257038-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li>SPU <font color='red'>-45%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16798990-skypeople-fruit-juice-announces-2672-500-registered-direct-offering\" target=\"_blank\">announcing</a> $2.7M direct offering.</li><li><a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='red'>-36%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16798241-sorrento-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcing</a> equity offering.</li><li><a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='red'>-14%</font>.</li><li><a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/ADPT' title='Adeptus Health'>ADPT</a> <font color='red'>-10%</font>.</li><li><a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='red'>-6%</font>&nbsp;on FQ4 <a href=\"https://seekingalpha.com/news/3256909-pier-1-imports-beats-0_01-misses-revenue\" target=\"_blank\">earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3257038\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$FTFT $SRNE $NADL - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3257038-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3257038-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257037\" data-ts=\"1492089060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257037-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+39%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16798285-ocera-therapeutics-announces-presentation-data-showing-ocrminus-002-prevented-progression\" target=\"_blank\">announcing</a> presentation of data showing OCR-002 prevented progression of fibrosis in preclinical model of non-alcoholic fatty liver disease.</li><li><a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products'>EYES</a> <font color='green'>+28%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16798624-second-sight-s-argus-ii-retinal-prosthesis-implanted-first-patient-asia\" target=\"_blank\">implanting</a> argus II retinal prosthesis system in the first patient in&nbsp;Asia.</li><li><a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='green'>+24%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3256950-applied-optoelectronics-sees-q1-results-far-guidance\" target=\"_blank\">reporting</a> 1Q17 revenue far above guidance.<br>     <a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a> <font color='green'>+6%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16798656-aehr-test-systems-announces-pricing-public-offering-common-stock\" target=\"_blank\">pricing</a> of its previously announced underwritten public offering of 3.84M shares of its common stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257037\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$OCRX $EYES $AAOI - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3257037-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3257037-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257036\" data-ts=\"1492088964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTFT\" target=\"_blank\">FTFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257036-skypeople-fruit-juice-announces-direct-offering-of-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SkyPeople Fruit Juice announces direct offering of shares</a></h4><ul> <li>SkyPeople Fruit Juice (SPU) announced that it has entered into an agreement with institutional investors covering the purchase shares for aggregate gross proceeds of $2,672,500 in a registered direct offering.</li><li>The offering is expected to close on or before April 17.</li> <li>In connection with the offering, the company will issue 862,097 registered shares of common stock at a purchase price of $3.10 per share.&nbsp; Concurrently in a private placement, for each share of common stock purchased by an investor, the investor will receive an unregistered warrant to purchase one share of common stock.&nbsp; The warrants have an exercise price of $5.20 per share and shall be initially exercisable six months following issuance.</li> <li>The net proceeds to the company from the transaction is expected to be approximately&nbsp;$2.41M. SkyPeople intends to use the cash to fund working capital and other general corporate purposes.</li><li>SPU&nbsp;<font color='red'>-44.51%</font>&nbsp;premarket to $2.88.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16798990-skypeople-fruit-juice-announces-2672-500-registered-direct-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3257036\" data-linked=\"SkyPeople Fruit Juice announces direct offering of shares\" data-tweet=\"$FTFT - SkyPeople Fruit Juice announces direct offering of shares https://seekingalpha.com/news/3257036-skypeople-fruit-juice-announces-direct-offering-of-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3257036-skypeople-fruit-juice-announces-direct-offering-of-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3257030\" data-ts=\"1492088318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DMPI\" target=\"_blank\">DMPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3257030-delmar-pharma-prices-equity-offering-shares-slip-25-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DelMar Pharma prices equity offering; shares slip 25% premarket</a></h4><ul><li>Thinly traded nano cap DelMar Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a>) slumps&nbsp;<font color='red'>25%</font>&nbsp;premarket on increased volume in response its <a href=\"https://seekingalpha.com/pr/16798842-delmar-pharmaceuticals-announces-pricing-9000-000-public-offering-common-stock-warrants\" target=\"_blank\">planned public offering</a> of 2,769,232 shares of common stock and five-year warrants to purchase up to 2,076,924 common shares at $3.50 at a combined price of $3.25. Net proceeds should be ~$8M.&nbsp;Closing date is April 18.</li><li>Yesterday's close was $4.07.</li></ul><div class=\"tiny-share-widget\" data-id=\"3257030\" data-linked=\"DelMar Pharma prices equity offering; shares slip 25% premarket\" data-tweet=\"$DMPI - DelMar Pharma prices equity offering; shares slip 25% premarket https://seekingalpha.com/news/3257030-delmar-pharma-prices-equity-offering-shares-slip-25-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3257030-delmar-pharma-prices-equity-offering-shares-slip-25-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256991\" data-ts=\"1492083656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256991-big-run-continues-for-adobe-guggenheim-climbs-on-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big run continues for Adobe as Guggenheim climbs on board</a></h4><ul><li>Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) has its fourth Buy initiation in two weeks - this morning <a href=\"https://www.streetinsider.com/Analyst+EPS+View/Guggenheim+Starts+Adobe+%28ADBE%29+at+Buy/12774620.html\" target=\"_blank\">from Guggenheim</a>.</li><li>Already&nbsp;<font color='green'>higher by 25%</font>&nbsp;this year, shares are&nbsp;<font color='green'>up another 2.2%&nbsp;</font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256991\" data-linked=\"Big run continues for Adobe as Guggenheim climbs on board\" data-tweet=\"$ADBE - Big run continues for Adobe as Guggenheim climbs on board https://seekingalpha.com/news/3256991-big-run-continues-for-adobe-guggenheim-climbs-on-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3256991-big-run-continues-for-adobe-guggenheim-climbs-on-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256987\" data-ts=\"1492082985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWNK\" target=\"_blank\">TWNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256987-hostess-brands-prices-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hostess Brands prices share offering</a></h4><ul> <li>Hostess Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/TWNK' title='Hostess Brands, Inc.'>TWNK</a>)&nbsp;prices its 20.1M &nbsp;share offering at $15.25 per share.</li><li>The selling stockholders consist of       funds managed by affiliates of Apollo Global Management, LLC, selling       approximately 18.7M shares; Gores Sponsor selling       approximately 900K shares; and an entity controlled by C. Dean       Metropoulos, selling approximately 500K shares.</li><li>Hostess will not receive       any proceeds from the offering.</li><li>TWNK  <font color='red'>-1.47%</font> premarket to  $15.42.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16798502-hostess-brands-inc-announces-pricing-public-offering-selling-stockholders\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3256987\" data-linked=\"Hostess Brands prices share offering\" data-tweet=\"$TWNK - Hostess Brands prices share offering https://seekingalpha.com/news/3256987-hostess-brands-prices-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3256987-hostess-brands-prices-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256986\" data-ts=\"1492082868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYES\" target=\"_blank\">EYES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256986-first-patient-in-asia-implanted-second-sights-argus-ii-shares-ahead-29-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First patient in Asia implanted with Second Sight&#39;s Argus II; shares ahead 29% premarket</a></h4><ul><li>Second Sight Medical Products (NASDAQ:<a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products'>EYES</a>) <a href=\"https://seekingalpha.com/pr/16798624-second-sight-s-argus-ii-retinal-prosthesis-implanted-first-patient-asia\" target=\"_blank\">announces </a>that the first patient in Asia, a blind 40-year old Taiwanese suffering from retinal degeneration, has been implanted with the Argus II Retinal Prosthesis System through an exclusive distribution partnership with Orient Europharma Co. Ltd. and charitable support from a Taiwan-based foundation.</li><li><a href=\"http://www.secondsight.com/argus-ii-retinal-prosthesis-system-en.html\" target=\"_blank\">Argus II&nbsp;</a>converts images captured by a miniature camera mounted on the patient's glasses into a series of tiny electrical pulses that are wirelessly transmitted to an array of electrodes implanted on the surface of the retina. The pulses stimulate the remaining viable retinal cells resulting in the perception of patterns of light. The patient regains some visual capability by learning to interpret the visual patterns.</li><li>Shares are up&nbsp;<font color='green'>29%</font>&nbsp;premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256986\" data-linked=\"First patient in Asia implanted with Second Sight&#39;s Argus II; shares ahead 29% premarket\" data-tweet=\"$EYES - First patient in Asia implanted with Second Sight&#39;s Argus II; shares ahead 29% premarket https://seekingalpha.com/news/3256986-first-patient-in-asia-implanted-second-sights-argus-ii-shares-ahead-29-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3256986-first-patient-in-asia-implanted-second-sights-argus-ii-shares-ahead-29-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256983\" data-ts=\"1492082135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOSY\" target=\"_blank\">MOSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256983-mosys-revises-operating-plan-to-cut-60-of-workforce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoSys revises operating plan, to cut 60% of workforce</a></h4><ul>     <li>MoSys (NASDAQ:<a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a>) <font color='red'>-38.6%</font> premarket after announcing a <a href=\"https://seekingalpha.com/pr/16798296-mosys-announces-revised-operating-plan\" target=\"_blank\">restructuring plan</a> that includes layoffs of ~60% of its total headcount.</li><li>MOSY says the revised operating plan will focus resources on the  production and sale of existing products while significantly  limiting new product development and R&amp;D activities.</li><li>MOSY also says it has initiated a process to explore and  review a range of strategic alternatives focused on maximizing stockholder value.</li></ul><div class=\"tiny-share-widget\" data-id=\"3256983\" data-linked=\"MoSys revises operating plan, to cut 60% of workforce\" data-tweet=\"$MOSY - MoSys revises operating plan, to cut 60% of workforce https://seekingalpha.com/news/3256983-mosys-revises-operating-plan-to-cut-60-of-workforce?source=tweet\" data-url=\"https://seekingalpha.com/news/3256983-mosys-revises-operating-plan-to-cut-60-of-workforce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256976\" data-ts=\"1492081354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256976-infosysminus-3_5-pledge-to-return-2b-to-shareholders-viewed-too-small\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infosys -3.5% as pledge to return $2B to shareholders viewed as too small</a></h4><ul>     <li>Infosys (NASDAQ:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>) says it will <a href=\"http://www.reuters.com/article/infosys-results-idUSL3N1HL25G\" target=\"_blank\">return $2B in cash to shareholders</a> (130B rupees), but shares are <font color='red'>-3.5%</font> premarket after guiding FY 2018 revenues below analyst consensus and disappointing some investors who expected a larger buyback.</li>     <li>While INFY reported in-line <a href=\"https://seekingalpha.com/news/3256944-infosys-limited-eps-line-misses-revenue\" target=\"_blank\">FQ4 earnings</a> and a 3.8% Y/Y improvement in revenues to 171B rupees (-0.9% Q/Q; flat in constant currency terms), the company forecasts FY 2018 revenues rising 6.5%-8.5% Y/Y (in constant currency) to 729B-743B rupees vs. consensus 743B rupees.</li>     <li>\"It's a lackluster kind of result and guidance,\" said Dipen Shah, head of private client group research at Kotak Securities.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3256976\" data-linked=\"Infosys -3.5% as pledge to return $2B to shareholders viewed as too small\" data-tweet=\"$INFY - Infosys -3.5% as pledge to return $2B to shareholders viewed as too small https://seekingalpha.com/news/3256976-infosysminus-3_5-pledge-to-return-2b-to-shareholders-viewed-too-small?source=tweet\" data-url=\"https://seekingalpha.com/news/3256976-infosysminus-3_5-pledge-to-return-2b-to-shareholders-viewed-too-small\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3256971\" data-ts=\"1492080744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JPM\" target=\"_blank\">JPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3256971-jpmorgan-chase-beats-0_13-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan Chase beats by $0.13, beats on revenue</a></h4><ul><li>JPMorgan Chase (NYSE:<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a>): Q1 EPS of $1.65 <font color='green'>beats by $0.13</font>.</li><li>Revenue of $25.59B (+6.3% Y/Y) <font color='green'>beats by $710M</font>.</li><li>Shares <font color='green'>+1.3%</font> PM.</li><li><a href='https://www.jpmorganchase.com/corporate/investor-relations/document/1Q17_Earnings_Press_Release.pdf'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3256971\" data-linked=\"JPMorgan Chase beats by $0.13, beats on revenue\" data-tweet=\"$JPM - JPMorgan Chase beats by $0.13, beats on revenue https://seekingalpha.com/news/3256971-jpmorgan-chase-beats-0_13-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3256971-jpmorgan-chase-beats-0_13-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":46,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}